Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,465 total articles
MercadoLibre is trading at a premium but backs it up with durable growth, growing fintech scale, and strong free cash flow. Short-term noise from investment-driven margin compression and macro volatility has created a buying opportunity for investors willing to hold through the next phase of monetization. This trade targets a rebound toward the sto…
We think WLTH is attractively priced around $9.90. The market has punished Wealthfront for deposit outflows and noisy legal headlines, but with a $1.55B market cap and a clear path to margin recovery if rates stay elevated, the risk/reward favors a long position. We outline an actionable trade with entry, stop and target calibrated to a long-term 1…
Advanced Micro Devices has crossed the $1 trillion market-cap threshold and shows technical and fundamental momentum tied to AI-driven CPU and accelerator demand. We upgrade to a buy and lay out a clear trade: enter at $621.00, target $740.00, stop $560.00, horizon 180 trading days.
Reddit's advertising engine is accelerating: double-digit DAU growth, outsized ARPU gains and consecutive quarters of robust revenue expansion have outpaced the stock. At roughly $153.59 today and a market cap near $29.6B, the pullback offers an asymmetric risk-reward for disciplined buyers. We upgrade to Strong Buy with a mid-term (45 trading days…
Nano Labs (NA) is a small-cap fabless chip and AI-hardware play trading at $2.38 with a $55M market cap. After a painful H1 2026, management is pivoting to AI + Web3.0 hardware (iPollo ClawPC A1 Mini) and maintaining a strategic reserve of 70,000 BNB. The setup is speculative but actionable: a controlled long with tight risk controls and mid-term t…
Synchrony Financial is trading at roughly 8x earnings, offering a rare entry on a high-return consumer finance franchise. This trade idea lays out why the credit card and private-label finance machine can compound earnings, the valuation logic, key catalysts and clear entry/stop/target levels for a long-term (180 trading days) trade.
Freenome's SimpleScreen CRC positions the company to access a large colorectal cancer screening market. Technical momentum, light float and concentrated short interest create a favorable setup for a mid-term long trade. We lay out an entry at $16.40, a stop at $15.20 and a target at $21.00 over ~45 trading days.
Advanced Micro Devices is trading at fresh highs as AI agent demand and server CPU share gains accelerate. Balance-sheet strength, $8.4B in free cash flow and a management TAM projection for server CPUs support a swing trade targeting $700. The valuation is rich but priced for sustained AI adoption; we outline entry, stop and target for a 45-tradin…
Applied Materials (AMAT) is showing renewed momentum after three consecutive quarters of revenue growth, healthier margins and visible demand driven by AI, advanced packaging and rising chiplet assembly investment. The stock trades on solid fundamentals - $370B market cap, $11.68 EPS and meaningful free cash flow - but still at premium multiples wh…
Avalon Holdings (AWX) is a tiny, profitable waste-management and golf-operations company trading at a steep discount to book and generating meaningful free cash flow versus its ~$10M market cap. For willing microcap traders this is a long idea sized as a high-risk, event-driven value trade with clear entry, stop and target levels.
Sandisk (SNDK) is benefiting from structurally stronger NAND pricing and accelerated enterprise SSD demand tied to AI deployments. Fundamentals - including robust free cash flow ($11.5B) and a net-cash balance sheet - support another leg higher. This trade idea sets a disciplined entry at $1860, a stop at $1700, and a primary target at $2250 over a…
Insmed (INSM) is objectively expensive by traditional metrics - negative EPS, negative free cash flow, and a P/S above 20 - yet the stock is trading roughly 40% below its 52-week high. For traders willing to accept company-level execution risk, a disciplined long with a clear stop and a mid-term target captures a recovery to more constructive level…
AN2 Therapeutics currently trades like a busted biotech. One failed clinical program masks several potential value drivers - asset sale, licensing, or repurposing - that could re-rate the stock. This trade idea lays out an actionable long with entry, stop, and target, plus catalysts and clear risk points.
BNP Paribas has quietly improved its balance sheet and earnings mix. With capital buffers firmer and one-off volatility fading, the stock trades with an earnings-quality discount that creates a good risk/reward. Upgrade to Buy with a clear trade plan and defined stop.
Lennar (LEN) is trading at roughly 0.87x book value with a market cap near $19.6B and a conservative balance sheet. Recent Q3 results disappointed, but the combination of tangible equity cushion, a 2.6% dividend yield, and visible free cash flow makes a disciplined long trade attractive for a mid-term mean-reversion move toward book value.
Meta's Muse announcement and the app's #1 App Store spot on 09/21/2026 fueled a momentum surge. The rally pushed the stock to $749 and stretched both valuation and technical indicators. For traders, a short-on-strength setup with a mid-term horizon (45 trading days) offers an asymmetric opportunity: entry at $755, target $650, stop-loss $785.73. Th…
Pfizer ($27.74) is paying a tempting 6.2% yield, but today’s price reflects optimism that the company will deliver materially stronger 2029 profits. Fundamentals and cash flow don’t yet justify that optimism. We downgrade to Hold and recommend a disciplined profit-taking trade with clearly defined entry, target and stop for a mid-term horizon.
Accenture has the scale, cash flow and an aggressive AI growth playbook, but that same AI trend threatens Consulting’s margin-rich work. Valuation is still rich for a company facing margin compression, slower top-line growth and integration risk from an expanded acquisition agenda. I downgrade and recommend a tactical short with a 45-trading-day ho…
<p>AAR Corp. (AIR) has pulled back roughly 27% from its 52-week high of $154 to the $112–$118 area. That decline leaves a stock with solid recent top-line acceleration, improving margins and a market cap near $4.7B trading at ~25x trailing earnings and ~1.4x price-to-sales. Given continued strength in aftermarket parts, MRO demand and government so…
Meta’s Muse AI app vaulted the stock higher and pulled forward one of the clearest signals yet that management’s capex on AI and agentic software is starting to show product-market fit. Balance the momentum with an elevated valuation: this trade is a medium-horizon, tactical long to capture the re-rate while locking risk with a tight stop.
Advanced Micro Devices is now a $1 trillion company, powered by accelerating AI demand for CPUs and accelerators. The fundamentals support further upside, but the multiple is rich and technicals are overbought. This trade idea buys a disciplined long with a clear stop and a 180-trading-day horizon to let server adoption and product cycles play out.
<p>Gemini looks positioned to benefit from a sustainable pickup in crypto trading volumes and custody flows, yet recent price action has been muted. We see a clear, actionable long opportunity with defined entry, stop and target levels that capture both a near-term re-rate and a longer revaluation as revenues scale.</p>
Planet Labs runs a differentiated, sticky data business with daily Earth imagery, a $900M+ backlog and accelerating revenue. The stock is trading near $17 after a sustained pullback from a $51 52-week high. For traders willing to accept dilution risk and government concentration, a mid-term long offers attractive asymmetric upside, anchored by cont…
Western Midstream (WES) pays a high yield near 7.8% and is trading at roughly a mid-teens P/E with free cash flow of about $1.22B. For income investors willing to accept midstream cyclicality and leverage, I outline a long-term trade: buy at $46.35, target $52.00 and stop loss $42.00 — horizon 180 trading days — with explicit catalysts and risks.
SiTime is trading on strong momentum after a blowout Q2 and a strategic acquisition that pushes the company toward $1B revenue. Valuation is rich, but near-term catalysts (Q3 guide, Renesas close, margin expansion) and supportive technicals create a defined risk/reward for a mid-term swing trade. Entry, stop, and target included.
